Chennai: City-based Orchid Chemicals has received the final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Zaleplon Capsules.
With this approval, the total ANDA approval count of Orchid has gone up to 37, while the total ANDA filings stand at 58, the company said.
